The Proto-Oncogene TWIST1 Is Regulated by MicroRNAs

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Nairismägi, Maarja Liisa ^a   Füchtbauer, Annette ^a   Labouriau, Rodrigo ^a   Bramsen, Jesper Bertram ^a   Füchtbauer, Ernst Martin ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 145A 5P; MICRORNA 151 5P; MICRORNA 337 3P; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE REPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTO ONCOGENE; TRANSLATION REGULATION; TWIST1 GENE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CATTLE; CELL LINE; CELL MOVEMENT; CHICKENS; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENES; REPRESSOR PROTEINS; RNA INTERFERENCE; SEQUENCE ALIGNMENT; TWIST TRANSCRIPTION FACTOR;

MAMMALIA; MURINAE;

EID: 84878605676     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066070     Document Type: Article

References (61)

1. Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, et al. (1999) Twist is a potential oncogene that inhibits apoptosis. Genes Dev 13: 2207-2217.
2. Villavicencio EH, Yoon JW, Frank DJ, Füchtbauer EM, Walterhouse DO, et al. (2002) Cooperative E-box regulation of human GLI1 by TWIST and USF. Genesis 32: 247-258.
3. Ma L, Teruya-Feldstein J, Weinberg RA, (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
4. Cheng GZ, Zhang W, Wang LH, (2008) Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Res 68: 957-960.
5. Qin Q, Xu Y, He T, Qin C, Xu J, (2012) Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res 22: 90-106.
6. Hornik C, Brand-Saberi B, Rudloff S, Christ B, Füchtbauer EM, (2004) Twist is an integrator of SHH, FGF, and BMP signaling. Anat Embryol (Berl) 209: 31-39.
7. Krebs I, Weis I, Hudler M, Rommens JM, Roth H, et al. (1997) Translocation breakpoint maps 5 kb 3′ from TWIST in a patient affected with Saethre-Chotzen syndrome. Hum Mol Genet 6: 1079-1086.
8. Li CW, Xia W, Huo L, Lim SO, Wu Y, et al. (2012) Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer Res 72: 1290-1300.
9. Chang TM, Hung WC, (2012) Transcriptional repression of TWIST1 gene by Prospero-related homeobox 1 inhibits invasiveness of hepatocellular carcinoma cells. FEBS Lett 586: 3746-3752.
10. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, et al. (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10: 295-305.
11. Gort EH, van Haaften G, Verlaan I, Groot AJ, Plasterk RH, et al. (2008) The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene 27: 1501-1510.
12. Harris AL, (2002) Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47.
13. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
14. Eckert MA, Lwin TM, Chang AT, Kim J, Danis E, et al. (2011) Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 19: 372-386.
15. Dave N, Guaita-Esteruelas S, Gutarra S, Frias A, Beltran M, et al. (2011) Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J Biol Chem 286: 12024-12032.
16. Laursen KB, Mielke E, Iannaccone P, Füchtbauer EM, (2007) Mechanism of transcriptional activation by the proto-oncogene Twist1. J Biol Chem 282: 34623-34633.
17. Hebrok M, Füchtbauer A, Füchtbauer EM, (1997) Repression of muscle-specific gene activation by the murine Twist protein. Exp Cell Res 232: 295-303.
18. Spicer DB, Rhee J, Cheung WL, Lassar AB, (1996) Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 272: 1476-1480.
19. Thisse B, Stoetzel C, Gorostiza-Thisse C, Perrin-Schmitt F, (1988) Sequence of the twist gene and nuclear localization of its protein in endomesodermal cells of early Drosophila embryos. EMBO J 7: 2175-2183.
20. Simpson P, (1983) Maternal-Zygotic Gene Interactions during Formation of the Dorsoventral Pattern in Drosophila Embryos. Genetics 105: 615-632.
21. Chen ZF, Behringer RR, (1995) twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes & Development 9: 686-699.
22. el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, et al. (1997) Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15: 42-46.
23. Füchtbauer EM, (1995) Expression of M-twist during postimplantation development of the mouse. Dev Dyn 204: 316-322.
24. Gitelman I, (1997) Twist protein in mouse embryogenesis. Dev Biol 189: 205-214.
25. Nairismägi ML, Vislovukh A, Meng Q, Kratassiouk G, Beldiman C, et al. (2012) Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression. Oncogene 31: 4960-4966.
26. Erson AE, Petty EM, (2008) MicroRNAs in development and disease. Clin Genet 74: 296-306.
27. Cano A, Nieto MA, (2008) Non-coding RNAs take centre stage in epithelial-to-mesenchymal transition. Trends Cell Biol 18: 357-359.
28. Doench JG, Sharp PA, (2004) Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511.
29. Scaal M, Füchtbauer EM, Brand-Saberi B, (2001) cDermo-1 expression indicates a role in avian skin development. Anat Embryol (Berl) 203: 1-7.
30. Li L, Cserjesi P, Olson EN, (1995) Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev Biol 172: 280-292.
31. Franco HL, Casasnovas J, Rodriguez-Medina JR, Cadilla CL, (2011) Redundant or separate entities?--roles of Twist1 and Twist2 as molecular switches during gene transcription. Nucleic Acids Res 39: 1177-1186.
32. Kapinas K, Delany AM, (2011) MicroRNA biogenesis and regulation of bone remodeling. Arthritis Res Ther 13: 220.
33. Peinado H, Olmeda D, Cano A, (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428.
34. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
35. Mayr C, Bartel DP, (2009) Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673-684.
36. Li B, Han Q, Zhu Y, Yu Y, Wang J, et al. (2012) Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist. FEBS J 279: 2393-2398.
37. Haga CL, Phinney DG, (2012) MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. J Biol Chem 287: 42695-42707.
38. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710.
39. Zhang J, Guo H, Qian G, Ge S, Ji H, et al. (2010) MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network. Mol Cancer 9: 211.
40. Shi M, Du L, Liu D, Qian L, Hu M, et al. (2012) Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells. J Pathol 228: 148-157.
41. Pramanik D, Campbell NR, Karikari C, Chivukula R, Kent OA, et al. (2011) Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol Cancer Ther 10: 1470-1480.
42. Kent OA, Chivukula RR, Mullendore M, Wentzel EA, Feldmann G, et al. (2010) Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev 24: 2754-2759.
43. Girardot M, Pecquet C, Boukour S, Knoops L, Ferrant A, et al. (2010) miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. Blood 116: 437-445.
44. Moliterno AR, Hankins WD, Spivak JL, (1998) Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 338: 572-580.
45. Ding J, Huang S, Wu S, Zhao Y, Liang L, et al. (2010) Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 12: 390-399.
46. Wang Y, Lee CG, (2009) MicroRNA and cancer--focus on apoptosis. J Cell Mol Med 13: 12-23.
47. Annalisa P, Furio P, Ilaria Z, Anna A, Luca S, et al. (2008) Anorganic bovine bone and a silicate-based synthetic bone activate different microRNAs. J Oral Sci 50: 301-307.
48. Murray SS, Glackin CA, Winters KA, Gazit D, Kahn AJ, et al. (1992) Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells. J Bone Miner Res 7: 1131-1138.
49. Bialek P, Kern B, Yang X, Schrock M, Sosic D, et al. (2004) A twist code determines the onset of osteoblast differentiation. Dev Cell 6: 423-435.
50. Jukic DM, Rao UN, Kelly L, Skaf JS, Drogowski LM, et al. (2010) Microrna profiling analysis of differences between the melanoma of young adults and older adults. J Transl Med 8: 27.
51. Shih KK, Qin LX, Tanner EJ, Zhou Q, Bisogna M, et al. (2011) A microRNA survival signature (MiSS) for advanced ovarian cancer. Gynecol Oncol 121: 444-450.
52. Wiklund ED, Bramsen JB, Hulf T, Dyrskjot L, Ramanathan R, et al. (2011) Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer 128: 1327-1334.
53. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
54. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, et al. (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69: 4851-4860.
55. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601.
56. Li X, Zhang Y, Zhang H, Liu X, Gong T, et al. (2011) miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 9: 824-833.
57. Zhu K, Chen L, Han X, Wang J, (2012) Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells. Oncol Rep 27: 1027-1034.
58. Burns TF, Dobromilskaya I, Murphy SC, Gajula RP, Thiyagarajan S, et al. (2013) Inhibition of TWIST1 Leads to Activation of Oncogene-Induced Senescence in Oncogene Driven Non-Small Cell Lung Cancer.Mol Cancer Res: In press.
59. Bramsen JB, Pakula MM, Hansen TB, Bus C, Langkjaer N, et al. (2010) A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects. Nucleic Acids Res 38: 5761-5773.
60. Füchtbauer A, Lassen LB, Jensen AB, Howard J, Quiroga Ade S, et al. (2011) Septin9 is involved in septin filament formation and cellular stability. Biol Chem 392: 769-777.
61. Davison AC, Hinkley DV (1997) Bootstrap Methods and Their Application. NY USA: Cambridge University Press.161-175, 193 p.